1. Home
  2. STTK
  3. STTK News

Latest Shattuck Labs Inc. (STTK) News on June 7, 2025

Shattuck Labs First Quarter 2025 Earnings: US$0.27 loss per share (vs US$0.37 loss in 1Q 2024)
STTK

Simply Wall St.

a month ago

Shattuck Labs First Quarter 2025 Earnings: US$0.27 loss per share (vs US$0.37 loss in 1Q 2024)

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
STTK

GlobeNewswire

a month ago

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

3 Promising Penny Stocks With Market Caps Under $300M
STTK

Simply Wall St.

2 months ago

3 Promising Penny Stocks With Market Caps Under $300M

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
STTK

GlobeNewswire

2 months ago

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

Shattuck Labs Full Year 2024 Earnings: Misses Expectations
STTK

Simply Wall St.

2 months ago

Shattuck Labs Full Year 2024 Earnings: Misses Expectations

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
STTK

GlobeNewswire

2 months ago

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

STTK

MT Newswires

3 months ago

Leerink Partners Initiates Shattuck Labs at Outperform With $4 Price Target

Favourable Signals For Shattuck Labs: Numerous Insiders Acquired Stock
STTK

Simply Wall St.

3 months ago

Favourable Signals For Shattuck Labs: Numerous Insiders Acquired Stock

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
STTK

GlobeNewswire

4 months ago

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
STTK

GlobeNewswire

4 months ago

Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress
STTK

GlobeNewswire

4 months ago

Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress

Planet Image International Leads 3 US Penny Stocks To Consider
STTK

Simply Wall St.

4 months ago

Planet Image International Leads 3 US Penny Stocks To Consider

Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
STTK

GlobeNewswire

5 months ago

Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Shattuck Labs highlights upcoming key milestones in 2025
STTK

TipRanks

5 months ago

Shattuck Labs highlights upcoming key milestones in 2025

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025
STTK

GlobeNewswire

5 months ago

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

Barfresh Food Group And 2 Other US Penny Stocks To Consider
STTK

Simply Wall St.

5 months ago

Barfresh Food Group And 2 Other US Penny Stocks To Consider

Shattuck Labs Announces Participation in Upcoming December Conferences
STTK

GlobeNewswire

6 months ago

Shattuck Labs Announces Participation in Upcoming December Conferences

Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations
STTK

Simply Wall St.

7 months ago

Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations

Shattuck Labs sees cash runway into 2027
STTK

TipRanks

7 months ago

Shattuck Labs sees cash runway into 2027

Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights
STTK

GlobeNewswire

7 months ago

Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround
STTK

Zacks

7 months ago

Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround

STTK

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 10/09/2024

After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
STTK

Zacks

8 months ago

After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)

STTK

MT Newswires

8 months ago

Top Midday Decliners

Shattuck Labs stock craters following pipeline and job cuts
STTK

Pharmaceutical Technology

8 months ago

Shattuck Labs stock craters following pipeline and job cuts

STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
STTK

Zacks

8 months ago

STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls

Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts
STTK

TipRanks

8 months ago

Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts

STTK

MT Newswires

8 months ago

Top Midday Decliners

Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline
STTK

Benzinga

8 months ago

Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline

STTK

MT Newswires

8 months ago

Sector Update: Health Care Stocks Steady Premarket Tuesday

STTK

MT Newswires

8 months ago

Sector Update: Health Care

STTK

MT Newswires

8 months ago

Shattuck Labs Shares Fall After Halting Development of Potential Leukemia Treatment

Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway
STTK

GlobeNewswire

8 months ago

Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway

Shattuck Labs, Inc. (NASDAQ:STTK) is definitely on the radar of institutional investors who own 43% of the company
STTK

Simply Wall St.

8 months ago

Shattuck Labs, Inc. (NASDAQ:STTK) is definitely on the radar of institutional investors who own 43% of the company

Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Tops Revenue Estimates
STTK

Zacks

10 months ago

Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Tops Revenue Estimates

Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights
STTK

GlobeNewswire

10 months ago

Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference
STTK

GlobeNewswire

10 months ago

Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference

Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Deliver On Growth Plans?
STTK

Simply Wall St.

a year ago

Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Deliver On Growth Plans?

Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
STTK

Zacks

a year ago

Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?

STTK

MT Newswires

a year ago

Shattuck Labs Added to Russell 2000, Russell 3000 Indexes

Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes

STTK

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 06/27/2024

Yigal Nochomovitz Just Trimmed Price Target for Shattuck Labs, Inc. (NASDAQ:STTK)
STTK

Insider Monkey

a year ago

Yigal Nochomovitz Just Trimmed Price Target for Shattuck Labs, Inc. (NASDAQ:STTK)

STTK

MT Newswires

a year ago

--BTIG Downgrades Shattuck Labs to Neutral From Buy

Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
STTK

Zacks

a year ago

Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

STTK

MT Newswires

a year ago

Shattuck Labs Says FDA Grants Orphan Drug Designation to Leukemia Drug; Shares Rise

Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)

Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients
STTK

GlobeNewswire

a year ago

Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

Most Shareholders Will Probably Agree With Shattuck Labs, Inc.'s (NASDAQ:STTK) CEO Compensation
STTK

Simply Wall St.

a year ago

Most Shareholders Will Probably Agree With Shattuck Labs, Inc.'s (NASDAQ:STTK) CEO Compensation

After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
STTK

Zacks

a year ago

After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
STTK

GlobeNewswire

a year ago

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress

What Makes Shattuck Labs (STTK) a New Buy Stock
STTK

Zacks

a year ago

What Makes Shattuck Labs (STTK) a New Buy Stock

Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
STTK

Zacks

a year ago

Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?

Shattuck Labs First Quarter 2024 Earnings: Beats Expectations
STTK

Simply Wall St.

a year ago

Shattuck Labs First Quarter 2024 Earnings: Beats Expectations

STTK

GuruFocus.com

a year ago

Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results

Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates
STTK

Zacks

a year ago

Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates

Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
STTK

GlobeNewswire

a year ago

Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights

Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),
STTK

Simply Wall St.

a year ago

Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference

Shattuck Labs Full Year 2023 Earnings: Beats Expectations
STTK

Simply Wall St.

a year ago

Shattuck Labs Full Year 2023 Earnings: Beats Expectations

Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
STTK

GlobeNewswire

a year ago

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

Shattuck Labs Announces Participation in Upcoming March Conferences
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Participation in Upcoming March Conferences

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
STTK

PR Newswire

a year ago

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
STTK

GlobeNewswire

a year ago

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
STTK

Zacks

a year ago

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
STTK

Business Wire

a year ago

Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium

Are Investors Undervaluing Brandywine Realty Trust (BDN) Right Now?
STTK

Zacks

a year ago

Are Investors Undervaluing Brandywine Realty Trust (BDN) Right Now?

Unlocking Q4 Potential of Brandywine Realty Trust (BDN): Exploring Wall Street Estimates for Key Metrics
STTK

Zacks

a year ago

Unlocking Q4 Potential of Brandywine Realty Trust (BDN): Exploring Wall Street Estimates for Key Metrics

Fubo Makes Strategic Investment in BKFC, Will Stream BKFC 57 Live Event on February 2
STTK

Business Wire

a year ago

Fubo Makes Strategic Investment in BKFC, Will Stream BKFC 57 Live Event on February 2

Southside Bancshares Inc (SBSI) Reports Decline in Q4 Net Income Amid Strategic Asset Sales
STTK

GuruFocus.com

a year ago

Southside Bancshares Inc (SBSI) Reports Decline in Q4 Net Income Amid Strategic Asset Sales

STTK

Business Wire

a year ago

General American Investors Company Announces Action Taken by the Board of Directors

Cass Information Systems (CASS) Q4 Earnings and Revenues Top Estimates
STTK

Zacks

a year ago

Cass Information Systems (CASS) Q4 Earnings and Revenues Top Estimates

STTK

Business Wire

a year ago

General American Investors Company Preferred Stock – Dividend/Distribution

NIKOLA CORPORATION ANNOUNCES DATE FOR FOURTH QUARTER AND FULL YEAR 2023 RESULTS AND WEBCAST AND Q&A PLATFORM FOR SHAREHOLDERS
STTK

PR Newswire

a year ago

NIKOLA CORPORATION ANNOUNCES DATE FOR FOURTH QUARTER AND FULL YEAR 2023 RESULTS AND WEBCAST AND Q&A PLATFORM FOR SHAREHOLDERS

Eaton Vance Tax Advgd Gbl Div Inc Fd's Dividend Analysis
STTK

GuruFocus.com

a year ago

Eaton Vance Tax Advgd Gbl Div Inc Fd's Dividend Analysis

Bowman Consulting Group Ltd CFO Bruce Labovitz Sells 5,000 Shares
STTK

GuruFocus.com

a year ago

Bowman Consulting Group Ltd CFO Bruce Labovitz Sells 5,000 Shares

Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results
STTK

Business Wire

a year ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results

Chatham Lodging Trust Announces Fourth Quarter Earnings Call to be Held on Tuesday, February 27, 2024
STTK

Business Wire

a year ago

Chatham Lodging Trust Announces Fourth Quarter Earnings Call to be Held on Tuesday, February 27, 2024

Insider Sell: COO Michael Bruen Sells 5,000 Shares of Bowman Consulting Group Ltd
STTK

GuruFocus.com

a year ago

Insider Sell: COO Michael Bruen Sells 5,000 Shares of Bowman Consulting Group Ltd

3 Stocks to Buy in the Booming Field of Gene Editing
STTK

InvestorPlace

a year ago

3 Stocks to Buy in the Booming Field of Gene Editing

Charles Brandes Bolsters Stake in Phibro Animal Health Corp
STTK

GuruFocus.com

a year ago

Charles Brandes Bolsters Stake in Phibro Animal Health Corp

Nayax to Present at the 26th Annual Needham Growth Conference
STTK

GlobeNewswire

a year ago

Nayax to Present at the 26th Annual Needham Growth Conference

New EV Frontiers: 3 Stocks Ready to Drive Past Tesla in 2024
STTK

InvestorPlace

a year ago

New EV Frontiers: 3 Stocks Ready to Drive Past Tesla in 2024

Mercer International Inc. to Present at Upcoming CIBC Investor Conference
STTK

GlobeNewswire

a year ago

Mercer International Inc. to Present at Upcoming CIBC Investor Conference

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
STTK

GlobeNewswire

a year ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma
STTK

Business Wire

a year ago

Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma

Hain Celestial (HAIN) Poised on Reimagined Strategy, E-Commerce
STTK

Zacks

a year ago

Hain Celestial (HAIN) Poised on Reimagined Strategy, E-Commerce

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference
STTK

GlobeNewswire

a year ago

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
STTK

GlobeNewswire

a year ago

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

Here's Why You Should Add Olympic Steel (ZEUS) to Your Portfolio
STTK

Zacks

a year ago

Here's Why You Should Add Olympic Steel (ZEUS) to Your Portfolio

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
STTK

GlobeNewswire

a year ago

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Clean Earth Names New Chief Commercial Officer
STTK

GlobeNewswire

a year ago

Clean Earth Names New Chief Commercial Officer

Insider Sell: President & COO Brenton Turner Sells 80,000 Shares of Rover Group Inc (ROVR)
STTK

GuruFocus.com

a year ago

Insider Sell: President & COO Brenton Turner Sells 80,000 Shares of Rover Group Inc (ROVR)

Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
STTK

GlobeNewswire

a year ago

Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference

Clean Earth Introduces ReSolve™ PFAS Services
STTK

GlobeNewswire

a year ago

Clean Earth Introduces ReSolve™ PFAS Services

Here's Why Investors Should Retain MGM Resorts (MGM) Stock
STTK

Zacks

a year ago

Here's Why Investors Should Retain MGM Resorts (MGM) Stock

Donegal Insurance Group Names Two to Posts of Chief Operating Officer, SVP of Field Operations & National Accounts
STTK

GlobeNewswire

a year ago

Donegal Insurance Group Names Two to Posts of Chief Operating Officer, SVP of Field Operations & National Accounts

Share on Social Networks: